DOI QR코드

DOI QR Code

Pharmacological potential of Cordyceps militaris with enhanced Cordycepin production for anti-inflammatory and tumor cell anti-proliferative applications

  • Ha, Si-Young (Department of Environmental Materials Science, Institute of Agriculture and Life Science, Gyeongsang National University) ;
  • Jung, Ji-Young (Department of Environmental Materials Science, Institute of Agriculture and Life Science, Gyeongsang National University) ;
  • Yang, Jae-Kyung (Department of Environmental Materials Science, Institute of Agriculture and Life Science, Gyeongsang National University)
  • Received : 2022.09.07
  • Accepted : 2022.09.20
  • Published : 2022.09.30

Abstract

Cordyceps militaris mycelium extracts containing high amounts of cordycepin were evaluated in vitro for their anti-inflammatory and tumor cell growth-inhibitory activities. All extracts dose dependently inhibited the increased production of inflammatory mediators including reactive oxygen species (ROS), nitric oxide (NO), and 𝛽-hexosaminidase in lipopolysaccharide (LPS)-stimulated inflammatory cells. All extracts were evaluated for anti-proliferative activity against normal RBL-2H3 cells and diverse types of cancer cell lines, including HCT, MC5-7, U-87MG, AGS, and A549 cells. The extract showed the strongest growth inhibition (IC50 = 28.13 ㎍/mL) relative to vehicle-treated control cells against fibrosarcoma (MC5-7). We have demonstrated anti-inflammatory activity of C. militaris via inhibition of NO, ROS production, and 𝛽-hexosaminidase release in activated cells. C. militaris mycelium extract was also evaluated mechanistically and found to exert six types of anti-cancer activity, confirming its pharmacological potential. Our study suggests C. militaris use as a potential source of anti-inflammatory and anti-cancer agents. C. militaris may also be considered a functional food.

Keywords

Acknowledgement

This study was carried out with the support of 'R&D Program for Forest Science Technology (Project No. 2020186D10-2222-AA0261382116530003)' provided by Korea Forest Service (Korea Forestry Promotion Institute).

References

  1. Baram D, Vaday GG, Salamon P, Drucker I, Hershkoviz R, Mekori YA. 2001. Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-α. J Immunol 167: 4008-4016. https://doi.org/10.4049/jimmunol.167.7.4008
  2. Brown JM, Wilson TM, Metcalfe DD. 2008. The mast cell and allergic diseases: role in pathogenesis and implications for therapy. Clin Exp Immunol 38: 4-18.
  3. Das SK, Masuda M, Sakurai A, Sakakibara M. 2010. Medicinal uses of the mushroom Cordyceps militaris: current state and prospects. Fitoterapia 81: 961-968. https://doi.org/10.1016/j.fitote.2010.07.010
  4. Enhancement of cordycepin production in submerged cultures of Cordyceps militaris by addition of ferrous sulfate. Biochem Eng J 60: 30-35. https://doi.org/10.1016/j.bej.2011.09.014
  5. Gao GX, Li QM, Shen HH. 2009. Effect of Astragali-Cordyceps Mixtura on TGF-β/Smad signal pathway in the lung of asthma airway remodeling. J Ethnopharmacol 125: 68-74. https://doi.org/10.1016/j.jep.2009.06.012
  6. Geng X, Zhong D, Su L, Lin Z, Yang B. 2020. Preventive and therapeutic effect of Ganoderma lucidum on kidney injuries and diseases. Adv Pharmacol 87: 257-276. https://doi.org/10.1016/bs.apha.2019.10.003
  7. Jayesh K, Helen LR, Vysakh A, Binil E, Latha MS. 2017. Ethyl acetate fraction of Terminalia bellirica (Gaertn.) Roxb. fruits inhibits proinflammatory mediators via down regulating nuclear factor-κB in LPS stimulated RAW 264.7 cells. Biomed Pharmacother 95: 1654-1660. https://doi.org/10.1016/j.biopha.2017.09.080
  8. Jiang Q, Lou Z, Wang H, Chen C. 2019. Antimicrobial effect and proposed action mechanism of cordycepin against Escherichia coli and Bacillus subtilis. J Microbiol 57: 288-297. https://doi.org/10.1007/s12275-019-8113-z
  9. Kim M, Lim SJ, Kang SW, Um BH, Nho CW. 2014. Aceriphyllum rossii extract and its active compounds, quercetin and kaempferol inhibit IgE-mediated mast cell activation and passive cutaneous anaphylaxis. J Agric Food Chem 62: 3750-3758. https://doi.org/10.1021/jf405486c
  10. Li SP, Li P, Dong TT, Tsim KW. 2001. Determination of nucleosides in natural Cordyceps sinensis and cultured Cordyceps mycelia by capillary electrophoresis. Electrophoresis 22: 144-150. https://doi.org/10.1002/1522-2683(200101)22:1<144::AID-ELPS144>3.0.CO;2-T
  11. Matsuda H, Nakamura S, Yoshikawa M. 2016. Degranulation inhibitors from medicinal plants in antigen-stimulated rat basophilic leukemia (RBL-2H3) cells. Chem Pharm Bull 64: 96-103. https://doi.org/10.1248/cpb.c15-00781
  12. Naik SR, Wala SM. 2013. Inflammation, allergy and asthma, complex immune origin diseases: mechanisms and therapeutic agents. Recent Pat Inflamm Allergy Drug Discov 7: 62-95. https://doi.org/10.2174/1872213X11307010062
  13. Ong BY, Aziz Z. 2017. Efficacy of Cordyceps sinensis as an adjunctive treatment in kidney transplant patients: a systematic-review and meta-analysis. Complement Ther Med 30: 84-92. https://doi.org/10.1016/j.ctim.2016.12.007
  14. Onodera A, Nishiumi F, Kakiguchi K, Tanaka A, Tanabe N, Honma A, Yayama K, Yoshioka Y, Nakahira K, Yonemura S, Yanagihara I, Tsutsumi Y and Kawai Y. 2015. Short-term changes in intracellular ROS localisation after the silver nanoparticles exposure depending on particle size. Toxicol Rep 2: 574-579. https://doi.org/10.1016/j.toxrep.2015.03.004
  15. Piotrowski I, Kulcenty K, Suchorska W. 2020. Interplay between inflammation and cancer. Rep Pract Oncol Radiother 25: 422-427. https://doi.org/10.1016/j.rpor.2020.04.004
  16. Shih L, Tsai KL, Hsieh C. 2007. Effects of culture conditions on the mycelial growth and bioactive metabolite production in submerged culture of Cordyceps militaris. Biochem Eng J 33: 193-201. https://doi.org/10.1016/j.bej.2006.10.019
  17. Shin JS, Chung SH, Lee WS, Lee JY, Kim JL, Lee KT. 2018. Immunostimulatory effects of cordycepin-enriched WIB-801CE from Cordyceps militaris in splenocytes and cyclophosphamide-induced immunosuppressed mice. Phytother Res 32: 132-139. https://doi.org/10.1002/ptr.5960
  18. Suparmin A, Kato T, Dohra H, Park EY. 2017. Insight into cordycepin biosynthesis of Cordyceps militaris: Comparison between a liquid surface culture and a submerged culture through transcriptomic analysis. PloS ONE 12: e0187052. https://doi.org/10.1371/journal.pone.0187052
  19. Torre LA, Siegel RL, Ward EM, Jemal A. 2016. Global Cancer Incidence and Mortality Rates and Trends-An UpdateGlobal Cancer Rates and Trends-An Update. Cancer Epidemiol Biomark Prev 25: 16-27. https://doi.org/10.1158/1055-9965.EPI-15-0578
  20. Vinatoru, M. 2001. An overview of the ultrasonically assisted extraction of bioactive principles from herbs. Ultrason Sonochem 8: 303-313. https://doi.org/10.1016/S1350-4177(01)00071-2
  21. Waktola G, Temesgen T. 2018. Application of mushroom as food and medicine. Adv Biotechnol Microbiol 113: 1-4.
  22. Won SY, Park EH. 2005. Anti-inflammatory and related pharmacological activities of cultured mycelia and fruiting bodies of Cordyceps militaris. J Ethnopharmacol 96: 555-561. https://doi.org/10.1016/j.jep.2004.10.009
  23. Yan H, Shao D, Lao YH, Li M, Hu H, Leong KW. 2019. Engineering cell membrane-based nanotherapeutics to target inflammation. Adv Sci 6: 1900605. https://doi.org/10.1002/advs.201900605
  24. Yang P, Song P, Sun SQ, Zhou Q, Feng S, Tao JX. 2009. Differentiation and quality estimation of Cordyceps with infrared spectroscopy. Spectrochim Acta A Mol Biomol Spectrosc 74: 983-990. https://doi.org/10.1016/j.saa.2009.09.004
  25. Zhou X, Gong Z, Su Y, Lin J, Tang K. 2009. Cordyceps fungi: natural products, pharmacological functions and developmental products. J Pharm Pharmacol 61: 279-291. https://doi.org/10.1211/jpp/61.03.0002